An autopsy case of amyotrophic lateral sclerosis with prominent muscle cramps, fasciculation, and high titer of anti-voltage gated potassium channel (VGKC) complex antibody

Clinical Neurology

Volumn 54, Issue 1, 2014, Pages 32-37

  Sato, Aki ^a   Sakai, Naoko ^a,b   Shinbo, Junsuke ^a   Hashidate, Hideki ^a   Igarashi, Shuichi ^a   Kakita, Akiyoshi ^b   Yamazaki, Motoyoshi ^a,c  

^a NIIGATA CITY GENERAL HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Department of Internal Medicine   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); Anti VGKC complex antibody; Autopsy; Fasciculation; Muscle cramp

Indexed keywords

CYCLOSPORIN A; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RITUXIMAB; TAR DNA BINDING PROTEIN; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; CASE REPORT; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE COURSE; FASCICULATION; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; MALE; MIDDLE AGED; MOTONEURON; MUSCLE ATROPHY; MUSCLE CRAMP; MUSCLE WEAKNESS; NERVE CONDUCTION; PLASMAPHERESIS; RESPIRATORY FAILURE; RESPIRATORY SYSTEM;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOANTIBODIES; AUTOPSY; FASCICULATION; HUMANS; MALE; MIDDLE AGED; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 84892702483     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.54.32     Document Type: Article

References (21)

1. (Isaacs). Brain Nerve 2010;62:401-410.
2. Tahmoush AJ, Alonso RJ, Tahmoush G.P., et al Cramp-fasciculation syndrome: a treatable hyperexcitable peripheral nerve disorder. Neurology 1991;41:1021-1024.
3. Fleet WS, Watson RT From benign fasciculations and cramps to motor neuron disease. Neurology 1986;36:997-998.
4. Singh V, Gibson J, McLean B., et al Fasciculations and cramps: how benign? Report of four cases progressing to ALS. J Neurol 2011;258:573-578.
5. de Carvalho M., Swash M. Cramps, muscle pain, and fasciculations: not always benign? Neurology 2004;63:721-723.
6. Muscle cramp-fasciculation syndrome 2006;17:206-208.
7. de Carvalho M., Swash M. Fasciculation-cramp syndrome preceding anterior horn cell disease: an intermediate syndrome? J Neurol Neurosurg Psychiatry 2011;82:459-461.
8. Díaz-Manera J., Rojas-García R, Gallardo E, et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol 2007;3:405-410.
9. Nishihira Y, Tan CF, Onodera O, et al Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 2008;116:169-182.
10. Taylor BV, Gross L, Windebank AJ The sensitivity and specificity of anti-GM1 antibody testing. Neurology 1996;47: 951-955.
11. Stevens A, Weller M, Wiethölter H. A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1993;56:361-364.
12. Niebroj-Dobosz I., Jamrozik Z, Janik P., et al Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol Scand 1999;100: 238-243.
13. Nwosu VK, Royer JA, Stickler DE Voltage gated potassium channel antibodies in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010;11:392-394.
14. Cramp-fasiciculation, VGKC ALS 2010;50:745.
15. Fasciculation, VGKC 2013;53:173.
16. Lai M, Huijbers MG, Lancaster E, et al Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-785.
17. Irani SR, Alexander S, Waters P., et al Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-2748.
18. Kanai K, Kuwabara S, Misawa S., et al Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006;129:953-962.
19. Nakata M, Kuwabara S, Kanai K., et al Distal excitability changes in motor axons in amyotrophic lateral sclerosis. Clin Neurophysiol 2006;117:1444-1448.
20. Cheah BC, Lin CS, Park S.B., et al Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis. Clin Neurophysiol 2012;123:2460-2467.
21. Shibuya K, Misawa S, Arai K., et al Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical study. Exp Neurol 2011;232:149-153.